MedTrace Logo

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

NCT03407469 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2026-05-20

No results posted yet for this study

Summary

The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer.

This is an investigational study. Up to 260 participants will be enrolled in this multicenter study. Up to 170 will take part in MD Anderson.

Conditions

  • Cancer-related Venous Thromboembolism

Interventions

BEHAVIORAL

Questionnaires

Questionnaires completed at the time participant joins this study and then about 30 days, 3 months, 6 months, and 12 months after that. Questionnaires will be about quality of life and experiences with treatment for venous thromboembolism (VTE). It should take less than 10 minutes to complete the questionnaires each time.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Cristhiam M. Rojas Hernandez, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-12
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Colombia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03407469 on ClinicalTrials.gov